Investigating the civic emotion dynamics during the COVID-19 lockdown: Evidence from social media
Qianlong Zhao,
No information about this author
Yuhao He,
No information about this author
Yuankai Wang
No information about this author
et al.
Sustainable Cities and Society,
Journal Year:
2024,
Volume and Issue:
107, P. 105403 - 105403
Published: April 5, 2024
Language: Английский
Purpose in life and stress: An individual-participant meta-analysis of 16 samples
Journal of Affective Disorders,
Journal Year:
2023,
Volume and Issue:
345, P. 378 - 385
Published: Oct. 30, 2023
Language: Английский
Resilience reemerged in sustainable development goals: A perspective on easing COVID-19 restrictions in China
Zizhao Ni,
No information about this author
Wenwu Zhao,
No information about this author
Jinyu Wang
No information about this author
et al.
Applied Geography,
Journal Year:
2025,
Volume and Issue:
178, P. 103573 - 103573
Published: March 4, 2025
Language: Английский
Development and application of a UHPLC-MS/MS method for the simultaneous determination of firmonertinib and its main metabolite AST-5902 in rat plasma: a study on the in vivo drug interaction between firmonertinib and paxlovid
Peng-fei Tang,
No information about this author
Su‐su Bao,
No information about this author
Wenyan Xie
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: May 12, 2025
Due
to
the
potential
occurrence
of
drug
interactions,
combined
application
firmonertinib
and
paxlovid
carries
a
relatively
high
risk.
Nevertheless,
as
now,
there
has
been
no
comprehensive
research
on
interaction
between
paxlovid.
Our
aim
was
establish
validate
an
accurate,
stable,
rapid
simple
UPLC-MS/MS
method
for
simultaneous
determination
its
metabolite
AST-5902
in
rat
plasma,
which
applied
study
vivo
Gefitinib
selected
internal
standard.
After
protein
precipitation
plasma
samples
with
acetonitrile,
separation
carried
out
Shimadzu
LC-20AT
UHPLC.
The
chromatographic
column
Shim-pack
Volex
PFPP
(50
mm
×
2.1
mm,
1.8
μm),
mobile
phase
composed
0.1%
formic
acid
-
water
methanol.
Mass
spectrometry
detection
performed
using
8,040
mass
spectrometer
ESI+
MRM
mode.
precision,
accuracy,
recovery
matrix
effect
this
were
detected.
linearity
stability
assessed.
Subsequently,
parent
ions
typical
fragment
firmonertinib,
IS
are
respectively
m/z
569.25
→
72.15,
555.50
498.10
447.25→
128.20.
selectivity,
specificity,
linearity,
recovery,
effect,
accuracy
precision
all
adequately
verified.
results
showed
that
when
paxlovid,
AUC
Cmax
significantly
increased,
while
AUC,
Tmax,
decreased.
established
UHPLC-MS/MS
is
simple.
Paxlovid
exhibit
significant
inhibitory
metabolism
rats.
Language: Английский
Association of anxiety, depression symptoms and sleep quality with chronic kidney disease among older Chinese
Jing Huang,
No information about this author
Yanyan Mao,
No information about this author
Xuetao Zhao
No information about this author
et al.
Medicine,
Journal Year:
2023,
Volume and Issue:
102(43), P. e35812 - e35812
Published: Oct. 27, 2023
This
study
aimed
to
explore
the
association
of
anxiety,
depression
symptoms
and
sleep
quality
with
chronic
kidney
disease
(CKD)
among
older
Chinese
adults.
A
total
1025
participants
from
Longitudinal
Healthy
Longevity
Survey
(CLHLS,
2011-2012)
were
included
in
our
study.
The
Generalized
Anxiety
Disorder
scale
was
used
assess
anxiety
Center
for
Epidemiologic
Studies
Depression
Scale
evaluate
depressive
symptoms.
Logistic
regression
models
conducted
odds
ratios
(ORs)
95%
confidential
intervals
(CIs).
We
found
that
poor
positively
associated
albuminuria,
impaired
estimated
glomerular
filtration
(eGFR)
CKD,
after
adjusting
other
covariates.
For
symptom,
ORs
CIs
1.20
(1.15-1.38)
1.16
(1.12-1.35)
eGFR
1.18
(1.12-1.36)
respectively.
1.15
(1.05-1.23)
1.14
(1.05-1.20)
(1.05-1.22)
Compared
good
quality,
OR
CI
1.12
(1.04-1.35)
1.10
(1.02-1.30)
1.11
(1.03-1.32)
And
positive
more
evident
females,
body
mass
index
≥
28,
smoking
drinking
Anxiety,
are
CKD.
Future
cohort
studies
needed
confirm
results.
Language: Английский
AI as your ally: The effects of AI‐assisted venting on negative affect and perceived social support
Meilan Hu,
No information about this author
Xavier Cheng Wee Chua,
No information about this author
Shu Fen Diong
No information about this author
et al.
Applied Psychology Health and Well-Being,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 4, 2024
In
recent
years,
artificial
intelligence
(AI)
chatbots
have
made
significant
strides
in
generating
human-like
conversations.
With
AI's
expanding
capabilities
mimicking
human
interactions,
its
affordability
and
accessibility
underscore
the
potential
of
AI
to
facilitate
negative
emotional
disclosure
or
venting.
The
study's
primary
objective
is
highlight
benefits
AI-assisted
venting
by
comparing
effectiveness
through
a
traditional
journaling
platform
reducing
affect
increasing
perceived
social
support.
We
conducted
pre-registered
within-subject
experiment
involving
150
participants
who
completed
both
conditions
with
counterbalancing
wash-out
period
1-week
between
conditions.
Results
from
frequentist
Bayesian
dependent
samples
t-test
revealed
that
effectively
reduced
high
medium
arousal
such
as
anger,
frustration
fear.
However,
condition
did
not
experience
increase
support
loneliness,
suggesting
perceive
effective
assistance
This
study
demonstrates
promising
role
improving
individuals'
well-being,
serving
catalyst
for
broader
discussion
on
evolving
psychological
implications.
Language: Английский
From academia to addiction: understanding the mechanism behind how academic stress fuels social media addiction in PhD students
Along He,
No information about this author
Li Zhu
No information about this author
Current Psychology,
Journal Year:
2024,
Volume and Issue:
43(34), P. 27944 - 27956
Published: Aug. 16, 2024
Language: Английский
Reflecting on relaxing zero-COVID and moving forward with positivity: A population-based quantitative and qualitative study
Ruihua Li,
No information about this author
Chuanning Huang,
No information about this author
Beier Guan
No information about this author
et al.
Health Policy and Technology,
Journal Year:
2024,
Volume and Issue:
unknown, P. 100929 - 100929
Published: Oct. 1, 2024
Language: Английский
Who Can Help Me? Citizens’ Help-Seeking on Weibo During the Shanghai Lockdown
Disaster Medicine and Public Health Preparedness,
Journal Year:
2024,
Volume and Issue:
18
Published: Jan. 1, 2024
Abstract
Objective
In
the
context
of
Omicron-induced
lockdown
in
Shanghai,
this
paper
investigated
appeals
for
assistance
by
citizens
on
Weibo,
aiming
to
understand
their
principal
challenges
and
immediate
needs.
Methods
This
collected
Weibo
posts
(
N
=
1040)
containing
keyword
“Shanghai
Anti-epidemic
Help”
during
citywide
lockdown.
The
online
help
requests
from
Shanghai
were
analyzed
across
7
dimensions,
including
sought,
level
urgency,
recipient,
intended
beneficiary
help,
expression,
position,
emotion.
Results
study
found
that
most
common
related
social
isolation,
specifically
areas
home
community
(34.81%),
isolation
(10.86%),
personal
freedom
(7.31%).
Of
all
requests,
11.83%
deemed
very
urgent.
Most
sent
out
a
plea
Internet
users
(56.06%),
primarily
requesting
themselves
(26.25%)
or
families
(27.60%).
Conclusions
freedom,
food,
medical
care
frequently
sought
public,
public’s
positions
emotions
pessimistic.
relevant
findings
revealed
needs
status
city
closure,
providing
reference
emergency
preparedness
public
health
events
emergencies.
Language: Английский
The effect of the earliest COVID-19 outbreak on survival in uninfected advanced NSCLC patients receiving chemotherapy in Jiangsu Province, China: A retrospective cohort study
Heng Lu,
No information about this author
Yue Wang,
No information about this author
Guoqiang Feng
No information about this author
et al.
Medicine,
Journal Year:
2023,
Volume and Issue:
102(39), P. e34559 - e34559
Published: Sept. 29, 2023
Coronavirus
disease
2019
(COVID-19)
is
still
rampant
and
uncontrolled
across
the
globe.
China's
strict
epidemic
prevention
measures
have
had
an
impact
on
treatment
in
patients
with
non-small
cell
lung
cancer
(NSCLC).
The
aim
of
this
study
to
explore
COVID-19
outbreak
uninfected
NSCLC
patients.
chemotherapeutic
efficacy
survival
89
advanced
were
retrospectively
analyzed.
endpoints
overall
(OS),
progression-free
(PFS),
response
rate.
Forty
forty-nine
received
chemotherapy
during
nonoutbreak
periods,
respectively.
Mean
delay
time
was
12.8
months
for
stage
versus
5.68
(P
=
.003).
There
no
significant
difference
rates
discontinuation
between
2
groups
.055
.239).
Significant
not
detected
median
OS
(15.8
months)
16.0
(adjusted
hazard
ratio,
1.058;
95%
confidence
interval,
0.593-1.888;
P
.849);
Median
PFS
7.9
10.3
0.878;
interval
0.513-1.503;
.634).
also
statistical
control
rate
.137).
earliest
receiving
chemotherapy.
However,
mean
prolonged
outbreak.
Language: Английский